TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Jonel Pasula Reumatolog AB
Closing information (x1000 EUR)
| Closing information | 2025/12 | 2024/12 | 2023/12 |
| Turnover |
3
|
3 | |
| Financial expenses |
0
|
0 | |
| Earnings before taxes |
-1
|
2 | |
| EBITDA |
-2
|
1 | |
| Total assets |
58
|
68 | |
| Current assets |
58
|
68 | |
| Current liabilities |
44
|
43 | |
| Equity capital |
13
|
24 | |
| - share capital |
9
|
9 | |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2025/12 | 2024/12 | 2023/12 |
| Solvency |
22.4%
|
35.3% | |
| Turnover per employee |
3
|
3 | |
| Profit as a percentage of turnover |
-33.3%
|
66.7% | |
| Return on assets (ROA) |
-1.7%
|
2.9% | |
| Current ratio |
131.8%
|
158.1% | |
| Return on equity (ROE) |
-7.7%
|
8.3% | |
| Change turnover |
0
|
-1 | |
| Change turnover % |
-79%
|
3%
|
-27% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2025/12 | 2024/12 | 2023/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.